GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Acro Biomedical Co Ltd (OTCPK:ACBM) » Definitions » Capex-to-Operating-Income

Acro Biomedical Co (Acro Biomedical Co) Capex-to-Operating-Income : 0.00 (As of Jun. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Acro Biomedical Co Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Acro Biomedical Co's Capital Expenditure for the three months ended in Jun. 2023 was $0.00 Mil. Its Operating Income for the three months ended in Jun. 2023 was $-3.20 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Acro Biomedical Co Capex-to-Operating-Income Historical Data

The historical data trend for Acro Biomedical Co's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acro Biomedical Co Capex-to-Operating-Income Chart

Acro Biomedical Co Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Dec20 Dec21 Dec22
Capex-to-Operating-Income
Get a 7-Day Free Trial - - - - -

Acro Biomedical Co Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Acro Biomedical Co's Capex-to-Operating-Income

For the Medical Distribution subindustry, Acro Biomedical Co's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acro Biomedical Co's Capex-to-Operating-Income Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Acro Biomedical Co's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Acro Biomedical Co's Capex-to-Operating-Income falls into.



Acro Biomedical Co Capex-to-Operating-Income Calculation

Acro Biomedical Co's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -15.87
=N/A

Acro Biomedical Co's Capex-to-Operating-Income for the quarter that ended in Jun. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -3.195
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acro Biomedical Co  (OTCPK:ACBM) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Acro Biomedical Co Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Acro Biomedical Co's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Acro Biomedical Co (Acro Biomedical Co) Business Description

Traded in Other Exchanges
N/A
Address
12175 Visionary Way, Suite 1160, Fishers, IN, USA, 46038
Acro Biomedical Co Ltd develops and manufactures nutritional products. The company offers cordyceps fungus for medicinal purposes. It also sells cordycepin and cordyceps powder.
Executives
Pao-chi Chu director, 10 percent owner, officer: CEO 2F, NO. 356 SEC 1. DUNHUA S. RD., DA'AN DISTRICT, TAIPEI CITY F5 106

Acro Biomedical Co (Acro Biomedical Co) Headlines

No Headlines